Valganciclovir 71921-0210
Product NDC
71921-0210- Manufacturer
- Florida Pharmaceutical Products, Llc
- Dosage Form
- Powder, For Solution
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- July 1, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA216317
Need to source Valganciclovir? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Valganciclovir | 50 mg/mL |
Drug Class
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]DNA Polymerase Inhibitors [MoA]
Packaging Options(1)
1 BOTTLE in 1 CARTON (71921-210-12) / 100 mL in 1 BOTTLE